Anela Vukoja, PhD

Anela is a Principal at Apollo and shapes the R&D strategy and clinical development plans in the portfolio companies. She also evaluates new investment opportunities and supports company creation projects. She previously specialized in R&D strategy and served international biotech and pharma companies and top tier VCs and hedge funds at boutique consultancy Cantenion. Anela holds a PhD in neurobiology from the Free University of Berlin as well as bachelor’s and master’s degrees in molecular biology